Evidence map›Paper›PMID 27130633›Full record

ReviewClinical and translational medicine2016

Mitochondrial transplantation for therapeutic use.

James D McCully, Sidney Levitsky, Pedro J Del Nido, Douglas B Cowan

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Clinical and translational medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04998357 (Study Title), which is not on this map. Cited by 111 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 2 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04998357 narecruitingnot on this mapstarted 2021, after this paper: background citation

Study Title: Autologous Mitochondrial Transplant for Cerebral Ischemia

TypeinterventionalSponsorUniversity of WashingtonRan2021 to 2026Enrolled20ConditionsCerebral IschemiaArmsEndovascular autologous mitochondrial transplantation
3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 2 syntheses or guidelines pooled it, 206 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Cellular Mechanisms Enabling Mitochondria Transfer and Transplantation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

James D McCullyDivision of Cardiac Surgery, Boston Children's Hospital, 300 Longwood Ave., Enders Building, EN 407, Boston, MA, 02115, USA. james_mccully@hms.harvard.edu.ORCID http://orcid.org/0000-0003-1058-6976
Sidney LevitskyDivision of Cardiac Surgery, Beth Israel Deaconess Medical Center, 110 Francis Street, Suite 2A, Boston, MA, 02115, USA.
Pedro J Del NidoDivision of Cardiac Surgery, Boston Children's Hospital, 300 Longwood Ave., Enders Building, EN 407, Boston, MA, 02115, USA.
Douglas B CowanDepartment of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, 300 Longwood Ave., Endres Building, EN 312, Boston, MA, 02115, USA.
Boston Children's Hospital · USBeth Israel Deaconess Medical Center · US

Funding

Autogeneic Mitochondria: Surgical CardioprotectionR01HL103642 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MCCULLY, JAMES D · 2010 to 2013
$1.7M
NHLBI NIH HHS R01 HL103642
6 · The paper itself

Abstract

Mitochondria play a key role in the homeostasis of the vast majority of the body's cells. In the myocardium where mitochondria constitute 30 % of the total myocardial cell volume, temporary attenuation or obstruction of blood flow and as a result oxygen delivery to myocardial cells (ischemia) severely alters mitochondrial structure and function. These alterations in mitochondrial structure and function occur during ischemia and continue after blood flow and oxygen delivery to the myocardium is restored, and significantly decrease myocardial contractile function and myocardial cell survival. We hypothesized that the augmentation or replacement of mitochondria damaged by ischemia would provide a mechanism to enhance cellular function and cellular rescue following the restoration of blood flow. To test this hypothesis we have used a model of myocardial ischemia and reperfusion. Our studies demonstrate that the transplantation of autologous mitochondria, isolated from the patient's own body, and then directly injected into the myocardial during early reperfusion augment the function of native mitochondria damaged during ischemia and enhances myocardial post-ischemic functional recovery and cellular viability. The transplanted mitochondria act both extracellularly and intracellularly. Extracellularly, the transplanted mitochondria enhance high energy synthesis and cellular adenosine triphosphate stores and alter the myocardial proteome. Once internalized the transplanted mitochondria rescue cellular function and replace damaged mitochondrial DNA. There is no immune or auto-immune reaction and there is no pro-arrhythmia as a result of the transplanted mitochondria. Our studies and those of others demonstrate that mitochondrial transplantation can be effective in a number of cell types and diseases. These include cardiac and skeletal muscle, pulmonary and hepatic tissue and cells and in neuronal tissue. In this review we discuss the mechanisms leading to mitochondrial dysfunction and the effects on cellular function. We provide a methodology for the isolation of mitochondria to allow for clinical relevance and we discuss the methods we and others have used for the uptake and internalization of mitochondria. We foresee that mitochondrial transplantation will be a valued treatment in the armamentarium of all clinicians and surgeons for the treatment of varied ischemic disorders, mitochondrial diseases and related disorders.

Indexed as

Ischemia/reperfusion injuryMitochondriaMyocardiumSurgery

Identifiers

PMID27130633
PMCPMC4851669
OpenAlexW2343074919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.